- abnormal lens morphology / IMPC
- abnormal cornea morphology / IMPC
- corneal opacity / IMPC
- hyperactivity / IMPC
- decreased locomotor activity / IMPC
- abnormal gait / IMPC
- decreased exploration in new environment / IMPC
- decreased startle reflex / IMPC
- limb grasping / IMPC
- increased mean corpuscular volume / IMPC
- decreased vertical activity / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased prepulse inhibition / IMPC
- decreased grip strength / IMPC
- decreased food intake / IMPC
- increased fasting circulating glucose level / IMPC
C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg
Status | Available to order |
EMMA ID | EM:08755 |
International strain name | C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg |
Alternative name | EPD0038_4_F09 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Aspatm1b(EUCOMM)Wtsi |
Gene/Transgene symbol | Aspa |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Provider affiliation | Institute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0038_4_F09. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele (Gt(ROSA)26Sor |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Animals used for archiving | heterozygous C57BL/6NTacUSA |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Severe Canavan disease / Orphanet_314911
- Mild Canavan disease / Orphanet_314918
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased grip strength / IMPC
- hyperactivity / IMPC
- abnormal lens morphology / IMPC
- decreased food intake / IMPC
- decreased prepulse inhibition / IMPC
- decreased locomotor activity / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased fasting circulating glucose level / IMPC
- abnormal cornea morphology / IMPC
- decreased vertical activity / IMPC
- corneal opacity / IMPC
- decreased exploration in new environment / IMPC
- increased mean corpuscular volume / IMPC
- abnormal gait / IMPC
- limb grasping / IMPC
- decreased startle reflex / IMPC
MGI phenotypes (gene matching)
- decreased bone mineral density / MGI
- megacephaly / MGI
- tremors / MGI
- muscle weakness / MGI
- paralysis / MGI
- abnormal diencephalon morphology / MGI
- abnormal myelination / MGI
- demyelination / MGI
- abnormal oligodendrocyte morphology / MGI
- decreased body length / MGI
- decreased body weight / MGI
- decreased body size / MGI
- decreased anxiety-related response / MGI
- ataxia / MGI
- hyperactivity / MGI
- hypoactivity / MGI
- impaired coordination / MGI
- abnormal gait / MGI
- decreased startle reflex / MGI
- abnormal pain threshold / MGI
- seizures / MGI
- premature death / MGI
- abnormal brain morphology / MGI
- no abnormal phenotype detected / MGI
- gliosis / MGI
- abnormal neurotransmitter level / MGI
- spongiform encephalopathy / MGI
- decreased vertical activity / MGI
- astrocytosis / MGI
- abnormal muscle tone / MGI
- muscle hypertonia / MGI
- lethargy / MGI
- abnormal retinal ganglion layer morphology / MGI
- abnormal brainstem morphology / MGI
- abnormal enzyme/coenzyme level / MGI
- behavior/neurological phenotype / MGI
- axon degeneration / MGI
- jerky movement / MGI
- abnormal retinal nerve fiber layer morphology / MGI
- brain vacuoles / MGI
- abnormal brain white matter morphology / MGI
- enlarged lateral ventricles / MGI
- decreased total body fat amount / MGI
- decreased bone mineral content / MGI
- preweaning lethality, incomplete penetrance / MGI
- abnormal auditory brainstem response waveform shape / MGI
- increased or absent threshold for auditory brainstem response / MGI
- abnormal sphingolipid level / MGI
- decreased gamma-aminobutyric acid level / MGI
- decreased glutamic acid level / MGI
- increased aspartic acid level / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).